Effetto sul microcircolo della terapia con proteina C attivata ricombinante umana in pazienti con shock settico
2008 Cavazzuti, I; Rinaldi, L; Busani, S; Donno, L; Iacomini, E; Girardis, Massimo
Team sepsi intraospedaliero: esperienza preliminare
2008 Donno, L; Amateis, E; Rinaldi, L; Codeluppi, M; Girardis, Massimo
Relationship between polyclonal immunoglobulin therapy and colonization by Candida spp.
2012 Serafini, G.; Cavazzuti, I; Venturelli, C.; Girardis, Massimo
Analysis of Bevacizumab (Bev) Therapy, Bisphosphonate Use and Osteonecrosis of the Jaw (ONJ) in >1900 Patients Treated in Two Randomized, Controlled Trials
2009 Guarneri, Valentina; Miles, D; Robert, Nj; Dieras, Vc; Glaspy, J; Smith, Ie; Thomssen, C; Biganzoli, L; Taran, T; Conte, Pierfranco
Discordant HER2 Total and HER2 Homodimer Levels by HERmark Analysis in Matched Primary and Metastatic Breast Cancer FFPE Specimens.
2009 Leitzel, K; Conte, Pierfranco; Guarneri, Valentina; Barbieri, Elena; Huang, W; Ali, Sm; Haddad, M; Sperinde, J; Lie, Y; Weidler, J; Bates, M; Lipton, A.
Safety and Activity Report of a Randomized Phase II Trial of Preoperative Anthracycline-Based Chemotherapy Plus Lapatinib, Trastuzumab or Both in HER2 Positive Breast Cancer: CHERLOB Trial.
2009 Guarneri, Valentina; Frassoldati, A; Bottini, A; Cagossi, K; Piacentini, Federico; Ravaioli, A; Cavanna, L; Amadori, D; Bisagni, G; Giardina, G; Conte, Pierfranco
Preliminary safety data of preoperative chemotherapy plus trastuzumab, lapatinib or both in HER2-positive operable breast cancer
2007 Guarneri, Valentina; Frassoldati, A; Piacentini, Federico; Cagossi, K; Cavanna, L; Michelotti, A; Jovic, Gordana; Giovannelli, Simona; Ficarra, G; Oliva, C; Conte, Pierfranco
Renal safety of zoledronic acid in patients with bone metastases from breast cancer (BC) or other tumors treated with IV BisphosphonateS (BPS) for up to ten years
2004 Guarneri, Valentina; Donati, S; Nicolini, M; Conte, Pierfranco
Il paziente itterico grave
2009 Rinaldi, L; Girardis, Massimo
Preliminary report on 30 months experience of in-hospital sepsis team
2009 Zavatti, L; Donno, L; Barbieri, E; Amateis, E; Rinaldi, L; Codeluppi, M; Girardis, Massimo
Studio del microcircolo in pazienti con patologia epatica e/o shock settico
2008 Rinaldi, L; Donno, L; Cavazzuti, I; Ferrari, E; Amateis, E; Girardis, Massimo
Effects of intravenous IGM-enriched immunoglobulins on muscle tissue microcirculation in septic shock: a preliminary report
2009 Cavazzuti, I; Rinaldi, L; Braccini, Ms; Bertolotti, V; Andreotti, A; Busani, S; Girardis, Massimo
Effects of a correct use of recombinant human activated C protein in patients with septic shock
2009 Ferrari, E; Girardis, Massimo; Donno, L; Rinaldi, L; Iacomini, E.
Bronchoalveolar lavage (BAL) and supplementation with exogenous surfactant in adults with acute respiratory distress syndrome (ARDS)
2009 Busani, S; Cavazzuti, I; Fabbri, L; Lumachi, L; Lo Pardo, D; Michielan, F; Vassalli, Pa; Pacini, D; D’Este, G; Girardis, Massimo; Pasetto, Alberto
The use of blood products in massive bleeding: a preliminary report
2009 Giuliani, Enrico; Braccini, Ms; Cantaroni, C; Semeraro, G; Bertellini, E; De Palma, M; Marietta, M; Pinelli, G; Rambaldi, M; Girardis, Massimo
Early use of immunoglobulin in septic shock
2010 Cavazzuti, I; Rinaldi, L; Donno, L; Braccini, Ms; Busani, S; Girardis, Massimo
Venous-arterial PCO2 difference as an early predictor of organ dysfunction in the ICU
2010 Biagioni, E; Boni, E; Girardis, Massimo
Effects of sepsis resuscitation bundle in cirrhotic patients with septic shock
2010 Rinaldi, L; Ferrari, E; Trevisan, D; Donno, L; Girardis, Massimo
Modified Early Warning Score and identification of patients with severe sepsis
2010 Zavatti, L; Barbieri, E; Amateis, E; Girardis, Massimo
Long Term Effects of an in-Hospital Program on Sepsis Management in ICU
2011 Ferrari, E.; Serafini, G.; Trevisan, D.; Donno, L.; Rinaldi, L.; Girardis, Massimo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Effetto sul microcircolo della terapia con proteina C attivata ricombinante umana in pazienti con shock settico | 1-gen-2008 | Cavazzuti, I; Rinaldi, L; Busani, S; Donno, L; Iacomini, E; Girardis, Massimo | |
| Team sepsi intraospedaliero: esperienza preliminare | 1-gen-2008 | Donno, L; Amateis, E; Rinaldi, L; Codeluppi, M; Girardis, Massimo | |
| Relationship between polyclonal immunoglobulin therapy and colonization by Candida spp. | 1-gen-2012 | Serafini, G.; Cavazzuti, I; Venturelli, C.; Girardis, Massimo | |
| Analysis of Bevacizumab (Bev) Therapy, Bisphosphonate Use and Osteonecrosis of the Jaw (ONJ) in >1900 Patients Treated in Two Randomized, Controlled Trials | 1-gen-2009 | Guarneri, Valentina; Miles, D; Robert, Nj; Dieras, Vc; Glaspy, J; Smith, Ie; Thomssen, C; Biganzoli, L; Taran, T; Conte, Pierfranco | |
| Discordant HER2 Total and HER2 Homodimer Levels by HERmark Analysis in Matched Primary and Metastatic Breast Cancer FFPE Specimens. | 1-gen-2009 | Leitzel, K; Conte, Pierfranco; Guarneri, Valentina; Barbieri, Elena; Huang, W; Ali, Sm; Haddad, M; Sperinde, J; Lie, Y; Weidler, J; Bates, M; Lipton, A. | |
| Safety and Activity Report of a Randomized Phase II Trial of Preoperative Anthracycline-Based Chemotherapy Plus Lapatinib, Trastuzumab or Both in HER2 Positive Breast Cancer: CHERLOB Trial. | 1-gen-2009 | Guarneri, Valentina; Frassoldati, A; Bottini, A; Cagossi, K; Piacentini, Federico; Ravaioli, A; Cavanna, L; Amadori, D; Bisagni, G; Giardina, G; Conte, Pierfranco | |
| Preliminary safety data of preoperative chemotherapy plus trastuzumab, lapatinib or both in HER2-positive operable breast cancer | 1-gen-2007 | Guarneri, Valentina; Frassoldati, A; Piacentini, Federico; Cagossi, K; Cavanna, L; Michelotti, A; Jovic, Gordana; Giovannelli, Simona; Ficarra, G; Oliva, C; Conte, Pierfranco | |
| Renal safety of zoledronic acid in patients with bone metastases from breast cancer (BC) or other tumors treated with IV BisphosphonateS (BPS) for up to ten years | 1-gen-2004 | Guarneri, Valentina; Donati, S; Nicolini, M; Conte, Pierfranco | |
| Il paziente itterico grave | 1-gen-2009 | Rinaldi, L; Girardis, Massimo | |
| Preliminary report on 30 months experience of in-hospital sepsis team | 1-gen-2009 | Zavatti, L; Donno, L; Barbieri, E; Amateis, E; Rinaldi, L; Codeluppi, M; Girardis, Massimo | |
| Studio del microcircolo in pazienti con patologia epatica e/o shock settico | 1-gen-2008 | Rinaldi, L; Donno, L; Cavazzuti, I; Ferrari, E; Amateis, E; Girardis, Massimo | |
| Effects of intravenous IGM-enriched immunoglobulins on muscle tissue microcirculation in septic shock: a preliminary report | 1-gen-2009 | Cavazzuti, I; Rinaldi, L; Braccini, Ms; Bertolotti, V; Andreotti, A; Busani, S; Girardis, Massimo | |
| Effects of a correct use of recombinant human activated C protein in patients with septic shock | 1-gen-2009 | Ferrari, E; Girardis, Massimo; Donno, L; Rinaldi, L; Iacomini, E. | |
| Bronchoalveolar lavage (BAL) and supplementation with exogenous surfactant in adults with acute respiratory distress syndrome (ARDS) | 1-gen-2009 | Busani, S; Cavazzuti, I; Fabbri, L; Lumachi, L; Lo Pardo, D; Michielan, F; Vassalli, Pa; Pacini, D; D’Este, G; Girardis, Massimo; Pasetto, Alberto | |
| The use of blood products in massive bleeding: a preliminary report | 1-gen-2009 | Giuliani, Enrico; Braccini, Ms; Cantaroni, C; Semeraro, G; Bertellini, E; De Palma, M; Marietta, M; Pinelli, G; Rambaldi, M; Girardis, Massimo | |
| Early use of immunoglobulin in septic shock | 1-gen-2010 | Cavazzuti, I; Rinaldi, L; Donno, L; Braccini, Ms; Busani, S; Girardis, Massimo | |
| Venous-arterial PCO2 difference as an early predictor of organ dysfunction in the ICU | 1-gen-2010 | Biagioni, E; Boni, E; Girardis, Massimo | |
| Effects of sepsis resuscitation bundle in cirrhotic patients with septic shock | 1-gen-2010 | Rinaldi, L; Ferrari, E; Trevisan, D; Donno, L; Girardis, Massimo | |
| Modified Early Warning Score and identification of patients with severe sepsis | 1-gen-2010 | Zavatti, L; Barbieri, E; Amateis, E; Girardis, Massimo | |
| Long Term Effects of an in-Hospital Program on Sepsis Management in ICU | 1-gen-2011 | Ferrari, E.; Serafini, G.; Trevisan, D.; Donno, L.; Rinaldi, L.; Girardis, Massimo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- Contributo su RIVISTA3822
- Atti di CONVEGNO1
Data di pubblicazione
- 2020 - 2026353
- 2010 - 20191488
- 2000 - 20091478
- 1990 - 1999366
- 1980 - 1989125
- 1975 - 197912
Editore
- Editrice Kurtis Srl:via Luigi Zoj...49
- Bioscientifica Limited:22 Apex Co...39
- Ariesdue SRL:via Airoldi 11, 2206...34
- Mary Ann Liebert Incorporated:2 M...33
- Masson SPA:via Flli Bressan 2, I ...31
- Schweizerbart Science Publishers28
- Springer-Verlag25
- -23
- .23
- Edizioni Minerva Medica20
Rivista
- JOURNAL OF INVESTIGATIVE DERMATOLOGY108
- BLOOD76
- DOCTOR. OS71
- HORMONE RESEARCH IN PAEDIATRICS69
- JOURNAL OF PSYCHOSOMATIC RESEARCH69
- ANTIVIRAL THERAPY68
Keyword
- HIV93
- -71
- keratinocytes61
- apoptosis50
- consultation-liaison psychiatry49
- HUMAN IMMUNODEFICIENCY VIRUS TYPE...33
- HIV infection27
- TESTOSTERONE27
- oestrogen deficiency / oestrogen ...23
- p75NTR23
Lingua
- eng2991
- ita746
- fre9
- ger1
- gre1
- rus1
- spa1
Accesso al fulltext
- no fulltext2838
- reserved687
- open295
- partially open2
